NGM Biopharmaceuticals, Inc. Skyrocketed
Tue, Jan 02, 2024 at 07:39 PM
NGM Biopharmaceuticals, Inc. (NGM:NASDAQ) rocketted at $1.25, representing a gain of 45.5%. On Tue, Jan 02, 2024, NGM:NASDAQ touched a New 2-Week High of $1.25. From Tue, Dec 19, 2023, the stock recorded 50.00% Up Days and 66.67% Green Days
About NGM Biopharmaceuticals, Inc. (NGM:NASDAQ)
NGM Biopharmaceuticals Inc is a clinical-stage bio-pharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases.
Top 10 Gainers:
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 316.25%
- Akso Health Group (AHG:NASDAQ), 61.2%
- Dogness (International) Corporation (DOGZ:NASDAQ), 54.73%
- Polished Inc Com (POL:NYSEMKT), 52.24%
- VolitionRx Limited (VNRX:NYSEMKT), 46.44%
- NGM Biopharmaceuticals, Inc. (NGM:NASDAQ), 45.52%
- PolyPid Ltd. (PYPD:NASDAQ), 43.42%
- Kelso Technologies Inc. (KIQ:NYSEMKT), 42.17%
- Peak Bio Inc Com (PKBO:NASDAQ), 41.15%
- Cue Health Inc. (HLTH:NASDAQ), 40.43%